Pfizer, the leading pharmaceutical company, inaugurated a global drug development centre on IIT Madras Research Park campus here on Wednesday. This is the company’s first such facility in Asia.
The centre, which is one of the company’s 12 such centres in the world, will develop and support products in its global markets and manufacturing centres. The centre, set up at a cost of over ₹150 Crore, is spread over 61,000 square feet and has ten laboratories with cutting edge equipment.
The centre will develop small molecules, innovative formulations and active pharmaceutical ingredients for global markets, a release by the company said. “The centre’s capabilities will include the development of both, APIs and finished dosage forms (FDFs) of differentiated products such as complex/value-added formulations, controlled-release dosage forms, device-combination products, lyophilized injections, powder-fill products, and ready-to-use formulations.”
